According to Dr. Katzman, the motion-preserving artificial disc mimics normal human disc motion and is an excellent replacement device for failing fusions. Initially, the device was approved for single-level replacement, but the latest approval by the U.S. Food and Drug Administration includes two-level repair.
More articles on devices:
Dallen Medical announces first use of Compressyn Staple in human
Blue Belt Technologies adds Professor David Barrett to scientific advisory board
Large bone & joint devices market to reach $2B by 2020: 4 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
